Skip to main content

Advertisement

SpringerLink
Log in

Regression of Epstein–Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet

  • RAPID COMMUNICATION
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Charité Campus Virchow-Klinikum der Humboldt Universität, Dept. of Medicine, Division of Hematology/Oncology, Augustenburger Platz 1, D-13353 Berlin, Germany Tel: +49-30-45059268 Fax: +49-30-45059910 e-mail: markus.ruhnke@charite.de, , , , , , DE

    U. Schneider, M. Ruhnke & D. Huhn

  2. Institut f. Klinische Molekularbiologie, Haematologikum der GSF, Marchioninistraße 25, D-81377 München, Germany, , , , , , DE

    H.-J. Delecluse

  3. Universitätsklinikum Benjamin Franklin, Institut für Pathologie, Hindenburgdamm 30, D-12200 Berlin, Germany, , , , , , DE

    H. Stein

Authors
  1. U. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ruhnke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H.-J. Delecluse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Huhn
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 14 December 1999 / Accepted: 5 January 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, U., Ruhnke, M., Delecluse, HJ. et al. Regression of Epstein–Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. Ann Hematol 79, 214–216 (2000). https://doi.org/10.1007/s002770050581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050581

Search

Navigation